Worldwide Shipping Available
Here at STEMAXON, we aim to be the leader for drug development and disease modeling of sporadic Alzheimer’ disease - the most prevalent dementia worldwide. This ambition is based on the identification of new and validated molecular target(s) for the disease treatment and creation of innovative human disease models that can recapitulate Alzheimer’ disease-related neurodegeneration.
inquireries AND PRODUCT INFO
ADVANCED RESEARCH FOR LIFE